Successful administration of sugammadex in a patient with acute porphyria: A case report

European Journal of Anaesthesiology

Volumn 31, Issue 8, 2014, Pages 439-441

  Buijs, Evert J ^a   Scholten, Joep G F ^a   Ros, Johannes J W ^a  

^a GELRE HOSPITALS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUPIVACAINE; CARBOHYDRATE; CEFAZOLIN; ESOMEPRAZOLE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HEPARIN; LABETALOL; LISINOPRIL; METRONIDAZOLE; NORADRENALIN; OXAZEPAM; PROPOFOL; ROCURONIUM; SUFENTANIL; SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE;

ABDOMINAL SURGERY; ACUTE INTERMITTENT PORPHYRIA; AGED; ANTIBIOTIC PROPHYLAXIS; AORTA VALVE REPLACEMENT; APPENDECTOMY; BREAST CANCER; CASE REPORT; CENTRAL VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COPROPORPHYRIA; DESCENDING AORTA SURGERY; DISEASE EXACERBATION; DNA DETERMINATION; EPIDURAL ANESTHESIA; FEMALE; FEMORAL ARTERY; GENE MUTATION; HUMAN; HYPERTENSION; HYPOTENSION; ILIAC ARTERY OBSTRUCTION; INTERMITTENT CLAUDICATION; LETTER; NEUROMUSCULAR BLOCKING; OSTEOPOROSIS; PAIN; PORPHYRIA VARIEGATA; RECTUS ABDOMINIS MUSCLE; TOBACCO USE; WOUND DEHISCENCE; ABDOMINAL AORTA; COMPLICATION; ENDOVASCULAR SURGERY; SURGICAL WOUND DEHISCENCE;

AGED; ANESTHESIA, EPIDURAL; AORTA, ABDOMINAL; ENDOVASCULAR PROCEDURES; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; PORPHYRIA, VARIEGATE; SURGICAL WOUND DEHISCENCE;

EID: 84905487302     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000045     Document Type: Letter

References (12)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemias and the porphyrias. In: Scriver CR BA, Sly WS, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 2001. p. 2991.
2. Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ 2000; 320:1647-1651.
3. van Kleef JW, de Lange JJ, van Everdingen JJE, et al. Guideline neuraxial blockade and anticoagulation. Alphen aan de Rijn: van Zuiden Communication; 2004.
4. Desnick RJ, Balwani M. The Porphyrias. In: LongoDL,KasperDL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison's Principles of Intenal Medicine. New York: McGraw-Hill Medical; 2012. pp. 3167-3181.
5. Lourenco CM, Lee C, Anderson KE. Disorders of haem biosynthesis. In: Walter JvdBG, editor. Inborn metabolic diseases: diagnosis and treatment. New York: Springer; 2012. pp. 521-553.
6. James MF, Hift RJ. Porphyrias. Br J Anaesth 2000; 85:143-153.
7. Welliver M. New drug sugammadex: a selective relaxant binding agent. AANA J 2006; 74:357-363.
8. Groudine SB, Soto R, Lien C, et al. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104:555-562.
9. Yang LP, Keam SJ. Sugammadex: a review of its use in anaesthetic practice. Drugs 2009; 69:919-942.
10. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104:667-674.
11. Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007; 104:582-584.
12. Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007; 104:569-574.